2026 NPPES data Specialist NPI 1821096579 M.D.
Verify on CMS →

JAMES DEVANNEY, M.D.

Specialist in TORRINGTON, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 758 beneficiaries · Specialist avg: 1K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
83.3087/100
▲ 0 pts above national avg 83.1 · [object Object]
Industry payments
$375.1
13 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: JAMES DEVANNEY, M.D. is a Specialist ([object Object]) practicing in TORRINGTON, Connecticut with a Medicare Part D prescribing footprint of 3K claims across 758 beneficiaries — 13% brand-name prescribing . Their CMS MIPS Final Score of 83.3087/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $375.1 across 13 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: JAMES DEVANNEY, M.D. reported a CMS MIPS final score of 83.3087 out of 100, above the 83.1 national average, and filed 3,271 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

JAMES DEVANNEY, M.D. at a glance

Near national average

NPI registry status

Active

Issued 07/07/2005

NPI 1821096579

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

3,271 122% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

MIPS final score

83.3087/100 0.20870000000000744% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Connecticut

How Specialist compares to other specialties among Connecticut providers

Connecticut providers

Specialist share within Connecticut

1. Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Specialist share within Connecticut

Medicare quality performance — MIPS

JAMES DEVANNEY, M.D.'s 2023 MIPS final score plotted against the Specialist national average

Near national average
MIPS Final Score
83.3087/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Specialist) — 83.3087/100 vs national avg 83.1

0%100%National avg83%83.3%
MIPS final score (Specialist) — 83.3087/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JAMES DEVANNEY, M.D. is a Specialist provider practicing in TORRINGTON, Connecticut, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1821096579. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JAMES DEVANNEY, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 538 LITCHFIELD ST, TORRINGTON, CT, 06790, with a listed phone of (860) 496-8990. NPI 1821096579 was issued on 07/07/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DEVANNEY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,271 prescription claims written by this provider, covering 758 Medicare beneficiaries and totaling roughly $387K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 3.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83.3087/100 for the 2023 performance year (Quality 72.1678, Cost 56.9026), compared with the national average of 83.1.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

538 LITCHFIELD ST
TORRINGTON, CT 06790

Provider Details

NPI 1821096579
Specialty Specialist
Credentials M.D.
Gender Male
NPI Issued 07/07/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

83.3087
Final Score
Avg: 83.1
72.1678
Quality
56.9026
Cost
100
Promoting Interoperability

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JAMES DEVANNEY, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$375

Largest payer

Sumitomo Pharma America, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

JAMES DEVANNEY, M.D. — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 3,271 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,271
Total Claims
$387K
Total Drug Cost
758
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,869
Total Day Supply
197,949
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$277K
Generic Drug Cost
$108K
Opioid Claims
118 (3.6% rate)
Antibiotic Claims
211

Patient Demographics

Average Patient Age
75.4 years
Avg HCC Risk Score
1.42
Gender Split
29% female / 71% male
Age Distribution
<65: 54, 65-74: 296, 75-84: 287, 85+: 121

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tamsulosin Hcl
740
Finasteride
513
Dutasteride
286
Myrbetriq
Mirabegron
201
Estradiol
149
Oxybutynin Chloride Er
Oxybutynin Chloride
136
Testosterone Cypionate
125
Gemtesa
Vibegron
110
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
105
Solifenacin Succinate
91

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How JAMES DEVANNEY, M.D. fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

JAMES DEVANNEY, M.D.'s 3,271 claims are above the specialty average of 1,474.

Nearby Specialist Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as DEVANNEY.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is JAMES DEVANNEY, M.D.'s specialty?
JAMES DEVANNEY, M.D. specializes in Specialist and practices in TORRINGTON, Connecticut. Credentials: M.D..
How much does JAMES DEVANNEY, M.D. prescribe under Medicare Part D?
In 2023, JAMES DEVANNEY, M.D. wrote 3,271 Medicare Part D claims totaling $387K in drug costs for 758 beneficiaries.
What is JAMES DEVANNEY, M.D.'s Medicare quality score?
JAMES DEVANNEY, M.D. has a CMS MIPS Final Score of 83.3087/100 (Quality: 72.1678, Cost: 56.9026). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JAMES DEVANNEY, M.D. located?
JAMES DEVANNEY, M.D. is located at 538 LITCHFIELD ST, TORRINGTON, CT, 06790. Phone: (860) 496-8990.
What is JAMES DEVANNEY, M.D.'s NPI number?
JAMES DEVANNEY, M.D.'s National Provider Identifier (NPI) is 1821096579, issued on 07/07/2005.
Does JAMES DEVANNEY, M.D. prescribe more brand-name or generic drugs?
JAMES DEVANNEY, M.D.'s prescribing is 13% brand-name and 87% generic drugs by claim count, with $277K in brand drug costs.
Does JAMES DEVANNEY, M.D. prescribe opioids?
Yes, JAMES DEVANNEY, M.D. had 118 opioid claims in 2023 with an opioid prescribing rate of 3.6%.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does JAMES DEVANNEY, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JAMES DEVANNEY, M.D.'s most frequently prescribed drugs include Tamsulosin Hcl, Finasteride, Dutasteride. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JAMES DEVANNEY, M.D. accept Medicare?
JAMES DEVANNEY, M.D. appears in CMS Medicare data with 3,271 Part D claims and 758 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JAMES DEVANNEY, M.D.'s credentials?
JAMES DEVANNEY, M.D.'s NPI is 1821096579 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology